FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound selected from
and its pharmaceutically acceptable salt. The invention also relates to a pharmaceutical composition for the treatment of a disorder mediated by complement factor D, based on the said compound.
EFFECT: new compounds and a pharmaceutical composition based on them have been obtained, which can be used in medicine for the treatment of disorders mediated by complement factor D, for example, ophthalmic, respiratory, cardiovascular and other diseases.
25 cl, 19 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS FOR TREATING COMPLEMENT-MEDIATED DISORDERS | 2015 |
|
RU2703995C2 |
| TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DESTROYERS | 2017 |
|
RU2797244C2 |
| ESTROGEN RECEPTOR PROTEOLYSIS MODULATORS AND RELATED USES THEREOF | 2018 |
|
RU2797808C2 |
| SUBSTITUTED BIARYL ANALOGUES OF PIPERAZINYL PYRIDINE, THEIR APPLICATION IN THERAPY, PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL PREPARATION, METHODS OF REDUCTION OF CALCIUM CONDUCTIVITY AND INHIBITION OF BINDING OF CAPSAICIN RECEPTORS | 2005 |
|
RU2413726C2 |
| ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT-MEDIATED DISORDERS | 2015 |
|
RU2707749C2 |
| SUBSTITUTED PYRROLO[2,3-B]PYRIDINE AND PYRAZOLO[3,4-B]PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | 2020 |
|
RU2824583C2 |
| OXOAZEPANYLACETAMIDE AND OXOAZEPANYLPHENOXYACETAMIDE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND METHOD FOR INHIBITING HEPATITIS TYPE C VIRUS (HCV) REPLICATION | 2006 |
|
RU2415132C2 |
| SUBSTITUTED (2-AZABICYCLO[3.1.0]HEXANE-2-YL)PYRAZOLO[1.5-A]PYRIMIDINE AND IMIDAZO[1.2-B]PYRIDAZINE COMPOUNDS AS TRK KINASE INHIBITORS | 2019 |
|
RU2781618C2 |
| POLYMERS OBTAINED VIA POLYMERISATION UNDER EFFECT OF NITROXY RADICALS | 2006 |
|
RU2425057C2 |
| USING SIP RECEPTOR MODULATORS IN OPHTHALMOLOGY | 2006 |
|
RU2497513C2 |
